294.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$292.40
Offen:
$291.745
24-Stunden-Volumen:
639.29K
Relative Volume:
0.29
Marktkapitalisierung:
$158.47B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$6.62B
KGV:
24.09
EPS:
12.223
Netto-Cashflow:
$10.61B
1W Leistung:
-0.32%
1M Leistung:
+6.59%
6M Leistung:
+0.23%
1J Leistung:
-9.25%
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AMGN
Amgen Inc
|
294.35 | 156.19B | 34.76B | 6.62B | 10.61B | 12.22 |
![]()
LLY
Lilly Eli Co
|
811.74 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
187.59 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
228.72 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
129.85 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
84.57 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
2024-11-14 | Eingeleitet | Citigroup | Neutral |
2024-10-17 | Eingeleitet | Bernstein | Outperform |
2024-10-14 | Herabstufung | Truist | Buy → Hold |
2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
2023-11-02 | Hochstufung | Truist | Hold → Buy |
2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
2023-09-06 | Eingeleitet | HSBC Securities | Buy |
2023-04-24 | Bestätigt | Oppenheimer | Outperform |
2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-02-13 | Bestätigt | Truist | Buy |
2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
2022-02-09 | Bestätigt | Barclays | Equal Weight |
2022-02-09 | Bestätigt | Jefferies | Buy |
2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
2022-02-09 | Bestätigt | Oppenheimer | Outperform |
2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
2021-12-06 | Eingeleitet | Goldman | Buy |
2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
2020-10-28 | Eingeleitet | UBS | Neutral |
2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2020-10-12 | Hochstufung | Truist | Hold → Buy |
2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2020-10-09 | Herabstufung | Truist | Buy → Hold |
2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
2020-02-27 | Eingeleitet | Barclays | Equal Weight |
2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
2019-11-12 | Eingeleitet | SunTrust | Buy |
2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Sagespring Wealth Partners LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Wilmington Savings Fund Society FSB Has $15.97 Million Position in Amgen Inc. $AMGN - MarketBeat
Morningstar Investment Management LLC Makes New $1.14 Million Investment in Amgen Inc. $AMGN - MarketBeat
Alpine Woods Capital Investors LLC Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Cornerstone Wealth Group LLC Acquires 12,816 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Vest Financial LLC - MarketBeat
Amgen Inc. stock daily chart insights2025 Technical Overview & Smart Investment Allocation Tips - newser.com
(AMGN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Price-Driven Insight from (AMGN) for Rule-Based Strategy - news.stocktradersdaily.com
Aanika’s Journey: Life After a Severe Asthma Diagnosis - Amgen
Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention - Yahoo Finance
Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com
Amgen Inc. $AMGN Shares Bought by Sequoia Financial Advisors LLC - MarketBeat
Concurrent Investment Advisors LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN) - The Globe and Mail
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
The Best Dividend ETF to Invest $1,000 in Right Now - The Motley Fool
Will Amgen Inc. (AMG0) stock deliver stable dividendsJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com
Keener Financial Planning LLC Raises Stake in Amgen Inc. $AMGN - MarketBeat
With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing - Yahoo Finance
Natural Investments LLC Has $1.05 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Cwm LLC - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 8,411 Shares of Amgen Inc. $AMGN - MarketBeat
Sather Financial Group Inc Grows Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Fifth Third Wealth Advisors LLC - MarketBeat
Richardson Financial Services Inc. Has $66,000 Position in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation as Shares Show Renewed Momentum in the Biotech Landscape - simplywall.st
Will Amgen Inc. stock recover after recent drop2025 Support & Resistance & Consistent Profit Alerts - newser.com
Thompson Investment Management Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Cyndeo Wealth Partners LLC Has $6.97 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Commerzbank Aktiengesellschaft FI Sells 3,381 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Lowered by Drucker Wealth 3.0 LLC - MarketBeat
Lmcg Investments LLC Sells 2,659 Shares of Amgen Inc. $AMGN - MarketBeat
Horizon Bancorp Inc. IN Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
First Fiduciary Investment Counsel Inc. Buys 1,069 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Is Amgen Inc. (AMGN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? - MSN
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing - Bioprocess Online
Market reaction to Amgen Inc.’s recent newsMarket Risk Summary & Technical Confirmation Alerts - newser.com
Responsive Playbooks and the AMGN Inflection - news.stocktradersdaily.com
Quantitative breakdown of Amgen Inc. recent moveMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Is Amgen Inc. (AMG0) stock cheap by valuation metricsTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 20252025 Winners & Losers & AI Driven Stock Reports - newser.com
Will Amgen Inc. (AMG0) stock benefit from mergersJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - newser.com
Mainstay Capital Management LLC ADV Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Boosted by Copperwynd Financial LLC - MarketBeat
What moving averages say about Amgen Inc.July 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - newser.com
US Bancorp DE Has $198.15 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Insight Inv LLC Has $2.10 Million Position in Amgen Inc. $AMGN - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):